We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Ellyn Sternfield

Mintz

Results 1 to 5 of 98
Most popular |Most recent


340B, When a Price Adjustment is Not Really an Adjustment, and the Implications for CMS Efforts to Attack Drug Prices

USA - January 2 2019 The Federal Courts gave the America Hospital Association and 340B covered entities a late Christmas present and in doing so may have dealt a blow to...


Health Care Qui Tam Update

USA - November 5 2018 In this issue, we provide an overview of 62 recently unsealed qui tam cases and take an in-depth look at four of those cases. Two of the featured...

Benjamin M. Zegarelli, Kevin M. McGinty, Hope S. Foster.


Six Initiatives States May Pursue to Curb Drug Prices and the 340B Factor

USA - October 23 2018 For much of the past 18 months, the Trump Administration, and in particular CMS, have talked a good game regarding reducing pharmaceutical prices. On...


CMS Proposes to Reduce Payments for New Drugs under Medicare Part B

USA - July 20 2018 In an attempt to lower drug prices, CMS released a proposed rule last week to reduce payments for new drugs under the Part B program. CMS has proposed...

Matthew S. Mora.


Court of Appeals Weighs in on 340B

USA - July 18 2018 Timing is everything. In yesterday’s post on 340B, I stated in closing: There is still one more shoe to drop. On May 4, 2018, the U.S. Court of...